Peptide boom on bitcoin: Americans spend millions on "miracle drugs" through cryptocurrencies
The peptide market in the U.S. is experiencing explosive growth, and cryptocurrency has become a key driver of this process. In the first quarter of 2026, sellers of such drugs received $32 million in digital assets from American buyers. This is 700% more than in the same period a year earlier. On-chain analytics data confirms: Bitcoin and stablecoins are becoming the primary payment method for this shadowy but rapidly growing sector.
Peptides are marketed as aids for weight loss, muscle gain, and even life extension. Legal versions of these drugs that have undergone clinical trials can be found in pharmacy chains like Walgreens. However, the lion's share of online trade is concentrated in the gray zone. Cheaper analogs come from foreign labs, often without a prescription or insurance, and some packaging explicitly states they are not intended for human use.
Why Bitcoin Became the Currency of Choice
Traditional banks and payment systems refuse to serve such sellers due to high compliance risks. As a result, suppliers are forced to switch to cryptocurrencies. In my observation, this is a classic example of how regulatory pressure pushes a market into a decentralized financial ecosystem. For many buyers, such as 49-year-old U.S. marketer Zack, purchasing Bitcoin was their first experience with digital assets. He found a Chinese supplier of retatrutide (an analog of Eli Lilly's drug) who agreed to ship 20 vials for $240 — three times cheaper than on the U.S. market. The seller only accepted cryptocurrency.
Growth Stages and the TikTok Effect
Blockchain analysis reveals three key phases in the development of this market. Before 2025, it was a niche "underground" segment with a monthly inflow of about $200,000. Then interest was fueled by the Make America Healthy Again movement, coinciding with the appointment of Robert F. Kennedy Jr. as head of the U.S. Department of Health and Human Services. However, the real explosion occurred in late 2025 when the topic infiltrated the TikTok subculture of looksmaxxing — an obsession with improving appearance. The average monthly inflow quadrupled to $9.9 million, and in peak months exceeded $10 million.
Former Coinbase Global employee Sarah Graham estimated the annual turnover of this market at $100 million as early as 2023. According to TRM Labs, in 2025, digital asset inflows into the sector reached $41.4 million — a 20% increase year-over-year. TRM Labs' Global Director of Policy Ari Redboad rightly compares this dynamic to the early stages of Silk Road. In my view, the parallels are obvious: cryptocurrency once again serves as a tool to bypass traditional financial barriers in a high-risk niche.
Major Players Shift to Stablecoins
The market is highly uneven. The bulk of the volume is concentrated among a narrow group of large sellers with a broad customer base. Small players experiment with different coins, but professionals almost exclusively use Bitcoin and stablecoins. Among sellers with an average deposit of $1,000 or more, "stablecoins" dominate — a logical hedging strategy against volatility for large and cross-border purchases.
The Chinese Connection and Raw Material Base
The primary raw materials for peptides are produced in China. Chinese chemical companies are actively expanding their presence in this niche. According to Forbes, over the first three quarters of last year, peptide imports from China to the U.S. doubled to over $300 million. Notably, some suppliers have pivoted from the drug trade. For example, Chinese company Bigreat Technology, which previously supplied fentanyl and amphetamine precursors to Russia and Kazakhstan, created a separate legal entity, Zhengzhou DEPU Technology, to sell cosmetic peptides.
My analysis: This case is a vivid illustration of how cryptocurrencies are becoming not just a speculative asset but a real payment method in the shadow economy. A 700% year-over-year growth indicates that demand for peptides is enormous, and traditional financial systems are unable to service it. However, investors should remember: such markets are extremely volatile and carry high regulatory risks. Bitcoin here is merely a tool, not the cause of the boom.